PDF (98KB)
For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Sunao Manabe, Representative Director, President and COO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Executive Officer, Vice President, Corporate Communications Department Telephone: +81-3-6225-1126 http://www.daiichisankyo.com
TOKYO, Japan (August 31, 2017) - It was today reported by Nikkei Business that Daiichi Sankyo Company Limited received an acquisition offer from AstraZeneca. However, this is not the fact.
